MARKSANS PHARMA LIMITED

Other languages Marksans Pharma Limited Bombay S.E.

Equities

MARKSANS

INE750C01026

Market Closed - Bombay S.E. Other stock markets 03:30:46 14/05/2024 pm IST			5-day change	1st Jan Change
158.6 ^INR	+1.67%		-3.21%	-1.43%

18/04	Marksans Pharma's Goa Facility Gets Five Inspectional Observations from US FDA	MT
14/02	Transcript : Marksans Pharma Limited, Q3 2024 Earnings Call, Feb 14, 2024

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Marksans Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	13/02
Marksans Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11
Marksans Pharma Limited Announces US FDA Approval for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg	03/23/03
Marksans Pharma Limited Approves Payment of Dividend	28/23/28
Marksans Pharma Limited Appoints Shailaja Vardhan as an Independent Director	28/23/28
Marksans Pharma Ltd. Receives USFDA Approval for Guaifenesin Extended-Release Tablets	22/23/22
Marksans Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/23/11
Marksans Pharma Limited Recommends Payment of Dividend for the Financial Year 2022-23	08/23/08
Marksans Pharma Limited Announces That It Has Received Final Approval from the Us Food and Drug Administration for Its Abbreviated New Drug Application for Acetaminophen and Ibuprofen Tablets, 250 Mg/125 Mg	12/23/12
Marksans Pharma Limited Approves Declaration of Dividend for the Financial Year 2022-23, Payable on or After 12 June, 2023	30/23/30
Marksans Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2023	30/23/30
Marksans Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	30/23/30
Marksans Pharma Limited acquired Bulk Pharmaceutical Business of Tevapharm India Private Limited.	19/23/19
Marksans Pharma Limited Announces US FDA Approval for Famotidine Tablets USP, 10 Mg and 20 Mg	10/23/10
Marksans Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	13/23/13
Marksans Pharma Limited's Board intends to launch an Equity Buyback on July 8, 2022.	04/22/04

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW